Nuvectis Pharma (NVCT) Enterprise Value (2021 - 2026)
Nuvectis Pharma (NVCT) reported Enterprise Value of -$25.1 million for Q1 2026, up 16.05% on a YoY basis from -$21.6 million in Q1 2025, and up 20.65% sequentially from -$31.6 million in Q4 2025.
Nuvectis Pharma (NVCT) Enterprise Value (2021 - 2026) Analysis & Trends
Nuvectis Pharma (NVCT) has 6 years of Enterprise Value data on file, last reported at -$25.1 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 16.05% year-over-year to -$25.1 million; the trailing twelve-month figure through Mar 2026 stood at -$25.1 million (up 16.05% YoY), and the FY2025 full-year result was -$31.6 million, down 70.69% from the prior year.
- Enterprise Value advanced to -$25.1 million in Q1 2026, from -$31.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13.6 million in Q2 2022 to a low of -$35.4 million in Q3 2025.
- A 5-year average of -$22.3 million and a median of -$20.8 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value rose 26.36% in 2024 and tumbled 106.43% in 2025, its largest moves.
- Tracing NVCT's Enterprise Value over 5 years: stood at -$23.6 million in 2022, then increased by 18.96% to -$19.1 million in 2023, then rose by 3.1% to -$18.5 million in 2024, then plunged by 70.69% to -$31.6 million in 2025, then grew by 20.65% to -$25.1 million in 2026.
- Business Quant data shows NVCT's Enterprise Value at -$25.1 million in Q1 2026, -$31.6 million in Q4 2025, and -$35.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Nuvectis Pharma | 453.54 Mn | 453.54 Mn | - | -25.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.10 Mn |
| Dec 31, 2025 | -31.63 Mn |
| Sep 30, 2025 | -35.44 Mn |
| Jun 30, 2025 | -26.79 Mn |
| Mar 31, 2025 | -29.90 Mn |
| Dec 31, 2024 | -18.53 Mn |
| Sep 30, 2024 | -17.17 Mn |
| Jun 30, 2024 | -18.12 Mn |
| Mar 31, 2024 | -19.50 Mn |
| Dec 31, 2023 | -19.13 Mn |
| Sep 30, 2023 | -22.10 Mn |
| Jun 30, 2023 | -24.60 Mn |
| Mar 31, 2023 | -15.50 Mn |
| Sep 30, 2022 | -23.60 Mn |
| Jun 30, 2022 | -13.60 Mn |
| Mar 31, 2022 | -16.70 Mn |
| Dec 31, 2021 | -5.74 Mn |